Fennec Pharmaceuticals Inc.

The momentum for this stock is not very good. Fennec Pharmaceuticals Inc. has good growth characteristics. Fennec Pharmaceuticals Inc. is not very popular among insiders. Fennec Pharmaceuticals Inc. is a mediocre stock to choose.
Log in to see more information.
Fennec Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of sod...
FENC Fundamental Data by TradingView

News

Fennec Pharmaceuticals (NASDAQ:FENC) PT Lowered to $13.00
Fennec Pharmaceuticals (NASDAQ:FENC) PT Lowered to $13.00

Zolmax Fennec Pharmaceuticals (NASDAQ:FENC - Free Report) had its price target trimmed by HC Wainwright from $15.00 to $13.00 in a research note published on Thursday, Benzinga reports. The firm currently...\n more…

HC Wainwright Cuts Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $13.00
HC Wainwright Cuts Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $13.00

Zolmax Fennec Pharmaceuticals (NASDAQ:FENC - Free Report) had its price target lowered by HC Wainwright from $15.00 to $13.00 in a research note published on Thursday, Benzinga reports. HC Wainwright...\n more…

Research Analysts Set Expectations for Fennec Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:FENC)
Research Analysts Set Expectations for Fennec Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:FENC)

Ticker Report Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Cantor Fitzgerald dropped their FY2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued to clients...\n more…

Fennec Pharmaceuticals (NASDAQ:FENC) Given New $13.00 Price Target at HC Wainwright
Fennec Pharmaceuticals (NASDAQ:FENC) Given New $13.00 Price Target at HC Wainwright

Ticker Report Fennec Pharmaceuticals (NASDAQ:FENC - Get Free Report) had its price objective cut by equities research analysts at HC Wainwright from $15.00 to $13.00 in a note issued to investors on Thursday...\n more…

Craig Hallum Lowers Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $15.00
Craig Hallum Lowers Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $15.00

Ticker Report Fennec Pharmaceuticals (NASDAQ:FENC - Free Report) had its price target reduced by Craig Hallum from $17.00 to $15.00 in a research report sent to investors on Wednesday morning, Benzinga reports...\n more…

Fennec Pharmaceuticals Inc (NASDAQ:FENC) to Post Q3 2024 Earnings of ($0.18) Per Share, Capital One Financial Forecasts
Fennec Pharmaceuticals Inc (NASDAQ:FENC) to Post Q3 2024 Earnings of ($0.18) Per Share, Capital One Financial Forecasts

Zolmax Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Equities research analysts at Capital One Financial decreased their Q3 2024 earnings estimates for shares of Fennec Pharmaceuticals in a...\n more…